Skip to main content
Clinical Trials/NCT05572931
NCT05572931CompletedNot Applicable

Effect of Fu's Subcutaneous Needling on Postoperative Acute Pain in Patients With Lumbar Spine Surgery: a Single-blinded Randomized, Control Study

China Medical University Hospital1 site in 1 country49 target enrollmentStarted: March 8, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
49
Locations
1
Primary Endpoint
The total dosage of analgesic drug

Study Overview

Brief Summary

The goal of this clinical trial is to evaluate Fu's Subcutaneous Needling (FSN) in postoperative pain in patients with Lumbar Spine Surgery (LSS). The main questions it aims to answer are:

  • Is FSN effective for postoperative pain?
  • Dose FSN decrease the tissue hardness after LSS?
  • Dose FSN have the effect of anti-inflammatory after LSS?

Participants will receive routine analgesic and FSN after LSS. Researchers will compare Sham group to see if FSN being effective for postoperative pain.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Pain and neurological symptoms are caused by degeneration of the spine (L1-S1) and require surgery.
  • •One hour after lumbar spine surgery (evaluated after returning to the ward from the recovery room) Visual analogue scale (VAS) score ≥ 5 points
  • •After being explained, join the trial voluntarily and sign the subject's consent form.

Exclusion Criteria

  • •Pain caused by acute trauma.
  • •major diseases such as heart and lung failure, cancer, chronic kidney disease.
  • •psychiatric disorder.
  • •History of substance abuse.
  • •A history of spinal surgery.
  • •Refused sign the consent form.

Arms & Interventions

Sham comparator

Sham Comparator

In addition to the routine analgesic (Acetaminophen 500mg, TID), the patients were treated with sham FSN at the 1st, 24th, and 48th hours after surgery. The sham FSN was used a fine acupuncture needle without swaying movement and reperfusion approach.

Intervention: fine acupuncture needle (Device)

Experimental

Experimental

In addition to postoperative routine analgesic (Acetaminophen 500mg, TID), patients were received FSN treatment. The FSN insertion point and time are the same as control group. And then we performed swaying movement and reperfusion approach.

Intervention: Fu's Subcutaneous Needling(FSN) (Device)

Outcomes

Primary Outcomes

The total dosage of analgesic drug

Time Frame: The amount of intravenous opioid drug (Pethidine 50mg/vail) within 72 hours after surgery.

opioid drug (Pethidine 50mg/vail)

Change of Taiwanese version of the Brief Pain Inventory (BPI-T) Short Form

Time Frame: Change from Baseline BPI-T at the 1st、24th、48th、72nd hour after surgery.

BPI-T Short Form

Secondary Outcomes

  • Change of Blood serum TNF-α(Change from Baseline TNF-α at the 24th, 72nd hour, 1st month after surgery.)
  • Change of Blood serum C-reactive protein (CRP)(Change from Baseline CRP at the 24th, 72nd hour, 1st month after surgery.)
  • Change of Blood serum IL-1ẞ、IL-2、IL-6(Change from Baseline IL-1ẞ、IL-2、IL-6 at the 24th, 72nd hour, 1st month after surgery.)
  • Change of Tissue hardness (TH)(Change from Baseline TH at the 1st、24th、48th、72nd hour after surgery.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Chih-Ying Wu

Attending physician

China Medical University Hospital

Study Sites (1)

Loading locations...

Similar Trials